Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

730
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
730
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.3K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.3K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

782
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
782
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.7K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.7K
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

2.1K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
2.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.7K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relevant insights from personalized inhaled carbon monoxide dosing in a safety study in pneumonia and ARDS.

Respiratory research·2026
Same author

Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at Admission.

Critical care medicine·2026
Same author

Mapping lung stress to visualize spatial heterogeneity and occult ventilation-induced lung injury risk in acute respiratory distress syndrome.

American journal of respiratory and critical care medicine·2026
Same author

Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis: The Phase 2b ASTER Trial.

CHEST critical care·2026
Same author

Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 34 Trials including 114,326 Individuals.

medRxiv : the preprint server for health sciences·2025
Same author

Phenotypic and functional characterization of tumor-reactive T cells in malignant pleural effusions.

bioRxiv : the preprint server for biology·2025
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

2.8K

Preventing ARDS: progress, promise, and pitfalls.

Jeremy R Beitler1, David A Schoenfeld2, B Taylor Thompson3

  • 1Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital.

Chest
|October 8, 2014
PubMed
Summary
This summary is machine-generated.

Advances in critical care have reduced Acute Respiratory Distress Syndrome (ARDS) incidence. However, no pharmacologic treatments exist, and mortality remains high, prompting research into ARDS prevention strategies.

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.5K
Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS
07:20

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Published on: September 7, 2016

10.4K

Related Experiment Videos

Last Updated: Apr 23, 2026

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

2.8K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.5K
Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS
07:20

Lavage-induced Surfactant Depletion in Pigs As a Model of the Acute Respiratory Distress Syndrome ARDS

Published on: September 7, 2016

10.4K

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Clinical Research

Background:

  • Significant progress in critical care has led to a notable decrease in Acute Respiratory Distress Syndrome (ARDS) incidence.
  • Key factors contributing to this decline include low tidal volume ventilation, prompt resuscitation, and antimicrobial therapy.

Purpose of the Study:

  • To review the current landscape of Acute Respiratory Distress Syndrome (ARDS) research, focusing on prevention strategies.
  • To highlight the challenges and future directions in developing effective ARDS prevention therapies.

Main Methods:

  • Review of recent advances in critical care and lung injury research.
  • Analysis of ongoing clinical trials investigating ARDS prevention agents.
  • Discussion of challenges in ARDS clinical trial design and endpoint validation.

Main Results:

  • While ARDS incidence has decreased due to improved critical care, mortality remains high.
  • No pharmacologic treatments for ARDS have been proven effective.
  • Prediction scores for identifying at-risk patients have been developed, and prevention trials are underway.

Conclusions:

  • Despite reduced incidence, ARDS remains a significant clinical challenge with high mortality.
  • The focus is shifting towards ARDS prevention, with ongoing trials for agents like aspirin and budesonide/formoterol.
  • Future research must address challenges in validating ARDS as a clinical trial endpoint and carefully evaluate the risks of potential preventive therapies.